dr. william k. oh discusses a biomarker development trial of satraplatin in patients with mcrpc
Published 10 years ago • 62 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:17
dr. oh on a biomarker development trial in mcrpc
-
1:52
william k. oh, md, on biomarkers and prostate cancer treatment algorithms
-
1:09
william oh, md, considers the role of biomarker selection trials in prostate cancer
-
1:42
dr. william oh describes updated findings from the cou-aa-302 trial
-
12:58
targeted and systematic prostate biopsy
-
22:00
how i live with stage 4 metastatic prostate cancer | mark's story | the patient story
-
36:08
colon cancer genetics
-
1:13
dr. william oh on combination therapy studies in prostate cancer
-
1:33
dr. oh discusses the utility of cabazitaxel
-
1:32
dr. william oh on prostate cancer monitoring
-
1:29
dr. william oh on the role of corticosteroids in treatment sequencing
-
1:22
dr. william oh discusses dasatinib in metastatic castration-resistant prostate cancer
-
1:47
william oh, md
-
1:15
dr. oh on the hormone-sensitive setting in prostate cancer
-
1:34
dr. william oh on treatment choices for prostate cancer
-
3:00
dr. william oh on corticosteroid use in the affirm study
-
1:23
william k. oh, md, considers the impact of apalutamide on m0 crpc patients
-
1:12
dr. oh on the management of hormone-sensitive prostate cancer
-
1:14
dr. william oh on what to ask about prostate cancer
-
1:34
william oh, md: comparison of chemotherapy to a secondary hormone at the time of progression
-
0:56
william oh, md: biggest concerns for elderly patients
-
0:40
what is colorectal cancer?